Table of Contents
Chromatography Research International
Volume 2013, Article ID 768160, 6 pages
http://dx.doi.org/10.1155/2013/768160
Research Article

Simultaneous Quantification of Glibenclamide, Simvastatin, and Quercetin by Using LC-UV Method and Its Application to Pharmacokinetic Study in Rats

1Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research-Ahmedabad, C/O-B. V. Patel Pharmaceutical Education and Research Development (PERD) Centre, S. G. Highway, Thaltej, Ahmedabad, Gujarat 380054, India
2Department of Pharmacology and Toxicology, B. V. Patel Pharmaceutical Education and Research Development (PERD) Centre, S. G. Highway, Thaltej, Ahmedabad, Gujarat 380054, India

Received 8 October 2013; Revised 26 November 2013; Accepted 26 November 2013

Academic Editor: Irene Panderi

Copyright © 2013 Vijay Duppala et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. K. Roberts and K. K. Sindhu, “Oxidative stress and metabolic syndrome,” Life Sciences, vol. 84, no. 21-22, pp. 705–712, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. A. H. Barnett, “Diabetes and hypertension,” British Medical Bulletin, vol. 50, no. 2, pp. 397–407, 1994. View at Google Scholar · View at Scopus
  3. P. Sikka, S. Kapoor, V. K. Bindra, M. Sharma, P. Vishwakarma, and K. K. Saxena, “Statin intolerance: now a solved problem,” Journal of Postgraduate Medicine, vol. 57, no. 4, pp. 321–328, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. D. R. Illingworth, J. R. Crouse III, D. B. Hunninghake et al., “A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial,” Current Medical Research and Opinion, vol. 17, no. 1, pp. 43–50, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Lazo, K. Parker, and L. Bruton, Goodmann and Gillmann's. The Pharmacological basis of therapeutics, The McGraw Hill, New York, NY, USA, 2007.
  6. P. J. K. Gruer, J. M. Vega, M. F. Mercuri, M. R. Dobrinska, and J. A. Tobert, “Concomitant use of cytochrome P450 3A4 inhibitors and simvastatin,” The American Journal of Cardiology, vol. 84, no. 7, pp. 811–815, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Patil, R. P. Dash, S. Anandjiwala, and M. Nivsarkar, “Simultaneous quantification of berberine and lysergol by HPLC-UV: evidence that lysergol enhances the oral bioavailability of berberine in rats,” Biomedical Chromatography, vol. 26, no. 10, pp. 1170–1175, 2012. View at Google Scholar
  8. J.-S. Choi, Y.-J. Piao, and K. W. Kang, “Effects of quercetin on the bioavailability of doxorubicin in rats: role of CYP3A4 and P-gp inhibition by quercetin,” Archives of Pharmacal Research, vol. 34, no. 4, pp. 607–613, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Lia, Y. Wei, F. Zhang, D. Wang, and X. Wu, “Changes in the pharmacokinetics of glibenclamide in rats with streptozotocin-induced diabetes mellitus,” Acta Pharmaceutica Sinica B, vol. 2, no. 2, pp. 198–204, 2012. View at Google Scholar
  10. S. Misaka, K. Kawabe, S. Onoue et al., “Green tea extract affects cytochrome P450 3A activity and pharmacokinetics of simvastatin in rats,” Drug Metabolism and Pharmacokinetics, 2013. View at Publisher · View at Google Scholar
  11. S. Wein and S. Wolffram, “Oral bioavailability of quercetin in horses,” Journal of Equine Veterinary Science, vol. 33, no. 6, pp. 441–445, 2013. View at Google Scholar